HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.

Abstract
Six new 4-hydroxycoumarin derivatives have been synthesized. They were characterized by UV-vis, IR, (1)H NMR, (13)C NMR, mass spectral data, elemental analysis, TLC and melting point determination. The new 4-hydroxycoumarin derivatives are studied by computational methods--DFT (B3LYP) and force field methods (MM2 and OPLS), in order to optimize their geometry and calculate quantum-chemical properties and conformational analysis. Five new 4-hydroxycoumarin derivatives were tested for cytotoxic activity in two tumor cell lines--HL-60 and EJ. The obtained results are compared with the utilized anticancer drug melphalan. Two of these compounds--ethyl 2-[(3,4-dihydroxyphenyl)(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-3-oxobutanoate (SS-16) and ethyl 2-[(4-hydroxy-2-oxo-2H-chromen-3-yl)(3-nitrophenyl)methyl]-3-oxobutanoate (SS-21) show comparatively good cytotoxic properties. Their activity is weaker than melphalan. SS-16 seems to be more active than SS-21.
AuthorsStancho Stanchev, Georgi Momekov, Frank Jensen, Ilia Manolov
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 43 Issue 4 Pg. 694-706 (Apr 2008) ISSN: 0223-5234 [Print] France
PMID17614164 (Publication Type: Journal Article)
Chemical References
  • 4-Hydroxycoumarins
  • Antineoplastic Agents
  • Melphalan
  • 4-hydroxycoumarin
Topics
  • 4-Hydroxycoumarins (chemical synthesis, chemistry, pharmacology)
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Computational Biology
  • Drug Screening Assays, Antitumor
  • HL-60 Cells (drug effects)
  • Humans
  • Melphalan (pharmacology)
  • Models, Molecular
  • Molecular Structure
  • Spectrophotometry, Infrared

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: